Edited by Peter Brzezinski a-Synuclein (aSyn) is a key player in the pathogenesis of Parkinson's disease and other synucleinopathies. Here, we report the existence of a novel soluble a-helical conformer of aSyn, obtained through transient interaction with lipid interfaces, and propose dynamic oligomerization as the mechanism underlying its stability. The conformational space of aSyn appears to be highly contextdependent, and lipid bilayers might thus play crucial roles as molecular chaperones in a cellular environment.
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease with a prevalence of approximately 1% in people over 60 years of age, increasing to 4% by age 85 [1] . Both genetic and histopathologic evidence convincingly implicate a-synuclein (aSyn) in the pathogenesis of PD [2] . Lipids also play a central role in aSyn's dynamics in physiology and disease. In fact, while aSyn's exact physiological function remains unknown, it has been increasingly associated with the regulation of synaptic vesicle exocytosis and recycling [3] . In addition, despite its classification as an archetypal 'intrinsically disordered protein' (IDP) [4] , aSyn adopts a predominantly a-helical structure when bound to lipid interfaces [5] . Its affinity is highest for highly curved bilayers of negatively charged lipids, similar to synaptic vesicles [5] . Recently, the purification and characterization of a soluble, a-helical aSyn tetramer also challenged the classic paradigm of aSyn's natively unfolded nature [6] . These results underscore the importance of characterizing the conformational space of putatively disordered proteins, particularly aSyn, in the presence of cytosolic folding determinants such as molecular crowding, interacting proteins, and lipid bilayers. In this work, we investigate how lipid interfaces can assist the refolding of an a-helical, soluble conformer of aSyn through transient interaction.
Materials and methods

Materials
1,2-ditridecanoyl-sn-glycero-3-phosphocholine (13:0 PC) was purchased from Avanti Polar Lipids (Alabaster, AL, USA) as dry powder. All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted.
Abbreviations BSA, bovine serum albumin; CD, circular dichroism; DLS, dynamic light scattering; DSC, differential scanning calorimetry; ELISA, enzymelinked immunosorbent assay; FRAP, fluorescence recovery after photobleaching; IDP, intrinsically disordered protein; ITC, isothermal titration calorimetry; LLOQ, lower limit of quantification; PBS, phosphate-buffered saline; PC, phosphatidylcholine; PD, Parkinson's disease; SEC, size-exclusion chromatography; SUVs, small unilamellar vesicles; TEM, transmission electron microscopy; aSyn, a-synuclein.
Protein expression and purification
A construct based on the sequence of human a-synuclein (aSyn) in pET5a was used to transform BL21(DE3) Escherichia coli. The bacteria were cotransformed with a pACYCDuet-1 plasmid containing cDNA encoding for both the catalytic (Naa20) and regulatory (Naa25) subunits of the fission yeast N-a-acetylation complex NatB (pNatB) [7] , a generous gift from Daniel P. Mulvihill (University of Kent, UK). Bacterial cultures were induced at an OD 600 of 0.5 with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 4 h. The cell pellet, after harvesting, was resuspended in 20 mM Tris buffer, 25 mM NaCl, pH 8.00, and lysed by boiling for 15 min. The supernatant of a 20 min, 20 000 g spin of the lysate was then further processed. The sample was loaded on two 5-mL (tandem) HiTrap Q HP anion exchange columns (GE Healthcare, Pittsburgh, PA, USA), equilibrated with 20 mM Tris buffer, 25 mM NaCl, pH 8.00. aSyn was eluted from the columns with a 25-1000 mM NaCl gradient in 20 mM Tris buffer, 1 M NaCl, pH 8.00. Peak fractions were pooled and injected on two 5-mL (tandem) HiTrap Phenyl HP hydrophobic interaction columns (GE Healthcare), equilibrated with 50 mM phosphate buffer, 1 M (NH 4 ) 2 SO 4 , pH 7.40. aSyn was eluted from the columns with a 1000-0 mM (NH 4 ) 2 SO 4 gradient in Milli-Q water. Peak fractions from the two peaks (N-aacetylated and non-N-a-acetylated aSyn) were further purified via gel filtration on a Superdex 200 XK 26/100 column (GE Healthcare) using 50 mM NH 4 Ac, pH 7.40 as running buffer. The peak fractions were lyophilized and N-terminal acetylation was validated by intact mass spectrometry. Lyophilized protein was kept at 4°C and reconstituted fresh, before experiments, in 10 mM NH 4 Ac, pH 7.40. The solution was also spun down every time after resuspension, before spectroscopic quantitation of the protein concentration, at 21 130 g for 20 min at 4°C to remove any large aSyn aggregates. Concentration was evaluated measuring the absorbance at 280 nm (e = 0.412 mgÁmL À1 Ácm À1 ).
Small unilamellar vesicles (SUVs) preparation
Lipid solutions were prepared fresh by resuspending the lyophilized lipids in 10 mM NH 4 Ac, pH 7.40 to their final concentrations and hydrating them for 30 min in a water bath, at a temperature higher than their T m . Small unilamellar vesicles were prepared by pulse-sonicating the phospholipid suspensions for 10-20 min at RT with a microtip sonicator (Misonix S-4000, Qsonica, Newtown, CT, USA). The vesicle suspensions were spun down at 21 130 g for 10 min to remove any metal particles and larger lipid aggregates.
Circular dichroism
Spectra and temperature scans were recorded with a Jasco 815 spectropolarimeter (Jasco, Easton, MD, USA 
Dynamic light scattering
The hydrodynamic radius of the SUVs was assessed using a DynaPro dynamic light scattering instrument (Wyatt Technology Corporation, Santa Barbara, CA, USA). The DLS cell was thermostated at 25.0°C; the hydrodynamic radii of the samples were obtained from the averages of 30 recordings of the same sample.
Transmission electron microscopy (TEM)
Transmission electron microscopy specimens were prepared on carbon-coated grids rendered hydrophilic by glow discharge. Samples, freshly prepared, were adsorbed on the grids with a 30-s incubation. For negatively stained samples, the grids were stained with 1% (w/v) aqueous uranyl acetate for 2 min. For immunogold-labeled samples, after sample adsorption on the grids, the grids were blocked with 1% BSA for 10 min, then incubated with primary antibody (15G7) in 1% BSA for 30 min, washed (39) for 10 min in PBS, then incubated with a rabbit-anti-rat bridging antibody in 1% BSA for 20 min. After three more washes in PBS (10 min), the grids were incubated in Protein A-gold 
Size-exclusion chromatography
Samples were injected on a Superdex 200 (10/300 GL) column (GE Healthcare) at RT and eluted with 50 mM NH 4 Ac, pH 7.40. For size estimation, a gel filtration standard (Catalog #151-1901, Bio-Rad, Hercules, CA, USA) was run on the column, and the calibration curve was obtained by semilogarithmic plotting of the molecular weights versus the elution volumes divided by the void volume.
ELISA
All materials were purchased from MSD (Meso Scale Discovery, Rockville, MD, USA) unless stated otherwise. ), added to the plate (30 lL per well) and shaken for 1 h at RT. After 5 TBS-T washes, MSD Read Buffer diluted 1 : 1 in ultrapure water was added and the plates were immediately measured using a MSD Sector 2400 imager. The Lower Limit of Quantification (LLOQ) was set at the signal from the blank plus 9 times the standard deviation from duplicate wells.
Quantitative phosphate analysis
The protocol used is adapted from Chen et al. [8] . Samples were transferred to the bottom of glass test tubes, 22.5 lL of~8.90 N H 2 SO 4 was added, and the mixture was heated for 25 min at 200-215°C. Next, 7.5 lL of 30% (v/v) H 2 O 2 was added to all of the tubes, after cooling them down to RT. After heating the samples again for 30 min at 200-215°C and cooling them down to RT, 195 lL of Milli-Q water and then 25 lL of a 2.5% (m/v) ammonium molybdate (VI) tetrahydrate solution were added. After addition of 25 lL 10% (m/v) ascorbic acid solution, the tubes were heated for 7 min at 100°C, and samples were cooled down again to RT. Absorbance at 820 nm was measured and phosphate concentration calculated using a calibration curve obtained from five phosphate samples ranging from 10 to 100 nmol, prepared from a 1000 mgÁL À1 phosphate standard solution for IC.
Data analysis and kinetic modeling
Global curve fitting for the unfolding data was performed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA) applying a biphasic model with all parameters constrained among the curves except for LogEC 50,2 and n H,2 (see Fig. S3 ). The final plateau value was set at 0 for all curves. The systems of kinetic differential equations were solved (either analytically or numerically) and plotted using Wolfram Mathematica 10 (Wolfram Research, Champaign, IL, USA) (see Appendix S1).
Results
To mimic the finely tunable lipid affinity and conformational flexibility of aSyn in a cellular setting, we used the binding of aSyn to phosphatidylcholine (PC) small unilamellar vesicles (SUVs) undergoing a phase transition [9] , which has been shown to be the mechanism underlying the localization of aSyn to lipid rafts [10, 11] . The affinity of aSyn for zwitterionic PC SUVs is driven by its insertion in the lipid packing defects, rather than by the electrostatic interactions involved in its well-characterized affinity for anionic vesicles [5] and, thus, is temperature-dependent [9] . Below their melting temperature (T m ), SUVs are highly strained gel-like (minimally fluid) systems with low curvature radii and an imperfect distribution of PC molecules, which allows aSyn to insert in the bilayers and fold in a predominantly a-helical structure. Since the formation of packing defects is induced by the liquid-disordered to gel-state phase transition, aSyn's binding and folding do not take place above the T m of the bilayers [9] . Using isothermal titration calorimetry (ITC), we measured binding sigmoids of aSyn to 13:0 PC SUVs at different temperatures (Fig. S1 ), confirming that no binding can be detected at temperatures above or close to the phase transition. In our protocol, we first mixed 13:0 PC SUVs and aSyn well above the T m and then lowered the temperature to allow membrane-binding and protein folding. Heating the sample above the T m should then release aSyn from the lipid vesicle, potentially preserving its secondary structure (Fig. 1A ). aSyn appears to retain its secondary structure, monitored using the 222-nm CD signal, at much higher temperatures in the upscan branch of the curves than in the downscan (Fig. 1B,C) , where the binding takes place roughly at the T m of the SUVs (~14°C) (Fig. 1C) . The degree of hysteresis presents a strong negative correlation with the temperature gradient speed used in the melting curve. While moving from 0.2 to 0.5°CÁmin À1 does not change significantly the outcome (data not shown), increasing the ramp to 1.0 or 2.0°CÁmin À1 leads to the loss of most of the fold at RT (Fig. 1C) . With the increase in the temperature gradient steepness, the oscillations in the signal around the T m increase in amplitude as well, possibly due to critical fluctuations originating from aSyn-induced membrane microdomains [12, 13] . However, the hysteresis in aSyn's helical content could also just be paralleling a structural hysteresis in the lipid bilayers, causing the release of the protein at much higher temperatures than T m . In order to exclude this possibility, we used differential scanning calorimetry (DSC). Lipid-bound aSyn can markedly reshape the phase transition, not only by shifting the T m but also by changing the profile of the DSC curve [9] . We thus recorded both downscan and upscan heat capacity curves of 13:0 PC SUVs, in the presence and absence of aSyn, using the same parameters as for the CD temperature scans. In the lipid-only scan, just one sharp peak is detected (both in the downscan and the upscan branch of the curve), corresponding to the phase transitions of the vesicles (Fig. 2A ). The T m shows a minor hysteresis (13.5°C in the downscan, 14.3°C in the upscan), a commonly observed phenomenon in lipid transitions [15] . The DSC curves recorded in the presence of the protein are virtually superimposable to the ones recorded in its absence ( Fig. 2A) . This implies that any effect on the lipid behavior due to bound protein must be extremely small and strongly argues against the possibility that aSyn's conformational hysteresis is due to a shift in the phase transition temperature of the SUVs. To directly compare the lipid behavior to the conformational transitions of the protein, we also took the first derivative of the CD signal of a representative 13:0 PC SUVs-aSyn scan. The differentiated temperature scan curve shows an excellent accord with the DSC in the downscan branch, with just one sharp peak at roughly the same temperature as the T m of the lipids (14.9°C) (Fig. 2B) . On the other hand, there is minimal change in the 222-nm ellipticity around the T m in the upscan, with only one broad peak around 40°C (accompanied by a shoulder around 30°C), indicating the unfolding of the protein in the absence of structural changes in the lipid membrane. We also studied the morphology and size of the lipid assemblies after a temperature scan, performed both in the presence and absence of aSyn, to check for possible remodeling effects of aSyn on the SUVs. Transmission electron microscopy micrographs show no difference in shape or size between the samples (Fig. 2C) and no difference in the hydrodynamic radii measured by dynamic light scattering (DLS) was detected (Fig. 2D) , further indicating that the structural changes in the lipid bilayers are completely reversible and cannot explain the conformational hysteresis of aSyn.
To confirm the soluble nature of the a-helical conformer of aSyn, we used both size-exclusion chromatography (SEC) (along with an ELISA-based quantification of aSyn and phosphate analysis to measure the 13:0 PC content in the SEC fractions) and TEM imaging coupled with aSyn immunogold labeling ( Figs 2E-G, S2) . For the SEC, the refolded aSyn-lipid mixture was immediately loaded on a Superdex 200 10/300 GL column and 1-mL fractions were collected and analyzed as described. The majority of aSyn (~80%) elutes, free from lipids, in the second UV peak, around 15 mL (Figs 2E, S2 ). This indicates a MW of about 60 kDa, in accord with the extended conformation of aSyn [4] . A fraction of the population of aSyn (~20%) coelutes with the SUVs in the first peak (eluting at the column's void volume, MW > 600 kDa), indicating the presence of a small amount of aSyn still bound to the membranes. The percentage of lipid-bound and lipid-unbound protein were compared to the percentage of folded protein after a temperature scan, confirming that the small amount of lipid-bound aSyn alone cannot account for the helical content of the refolded sample (Fig. 2G) . Using another independent technique, TEM imaging coupled with immunogold labeling of aSyn, we repeated the quantification of the two protein populations (lipid-bound and unbound) and once again found that aSyn is largely unbound from the SUVs (~80%, in excellent accord with the SEC+ELISA data) (Fig. 2F,G) .
We then moved on to characterize the stability of the soluble helical aSyn conformer. The slow temperature ramp required to maintain most of the a-helicity already suggested the presence of an irreversible process and, by extension, the existence of a kinetically trapped conformer (Fig. 1C) . A time course measurement, monitoring the helical content of aSyn, confirmed the metastable nature of the helical conformer. While the CD spectrum initially shows prominent a-helicity, the folded content disappears in an exponential fashion over the course of 42 h (Fig. 3A) .
Looking for mechanistical insights that could explain the extremely long half-life of an apparently unstable species as a folded, soluble, aSyn monomer, we measured via CD the unfolding kinetics of an undiluted refolded aSyn sample and of 1 : 2 and 1 : 4 dilutions of the same sample in buffer (Fig. 3B) . A CD spectrum of each of the three samples, incubated at RT, was obtained every 2-3 h until four superimposable spectra in a row were recorded, indicating the endpoint of the unfolding process. We observe a marked decrease in the time at the endpoint moving from the 1 : 1 sample (51 h) to the ones diluted 1 : 2 (39 h) and 1 : 4 (33.5 h), which would not be the case if the process was one of concerted unbinding and unfolding from a vesicle-bound state (Fig. 3C, inset) . On the other hand, this observation is consistent with a multimolecular event as the transient homo-oligomerization process, which would be slowed down by dilution (Fig. 3D, inset) . Decreasing the concentration of soluble, folded aSyn would decrease the rate of the self-association, causing a faster loss of fold of the helical monomer. We developed a mechanistic hypothesis for the observed trends; kinetic equations for the unbinding and unfolding from lipid bilayers were drafted, solved analytically, and plotted (Fig. 3C) . A model where the slow unbinding of aSyn is the cause of the protein's unfolding showed no dependence from the dilution factor (as intuitively expected, since such a mechanism would not involve any multimolecular steps), in contrast with our results. Time-dependent sigmoidal kinetic profiles, as observed in our experiment, are classically associated with autocatalytic events as in a dynamic homo-oligomerization, constantly transferring folded monomers to a pool of unfolding-resistant or partially unfolding-resistant helical multimers. A detailed account of the development of the kinetic equations is provided in the Appendix S1. It can be seen that, while lacking some quantitative insights (we cannot derive, for example, the average size of the multimers or the microscopic kinetic constants), the equations describe effectively the shape of the three curves and reproduce the trends observed with the change in the dilution factor (Fig. 3D) . Therefore, our results are in good agreement with the previous reports of metastable multimers arising upon interaction with vesicular membranes [16, 17] .
Discussion
We investigated the interplay of aSyn with 13:0 PC SUVs, binding partners characterized by the dependence of the protein's membrane affinity on the structure of the lipid bilayers, akin to its interaction with lipid rafts [10, 11] . By modulating aSyn's binding through phase transitions, we were able to reconstitute a soluble helical species. While folding of IDPs upon binding to ligands (either small molecules, nucleic acids, or other proteins) is well established and characterized in a wide number of cases [19, 20] , there is no previous report describing folding assisted by intermittent contact with a cofactor.
In addition, our findings could explain an old discrepancy between aSyn's strong affinity for charged curved lipid interfaces [5] and the fact that it is consistently purified as a predominantly cytosolic protein Global fitting of the data using a biphasic (doublesigmoid) model was performed sharing all but two parameters among the curves and setting the plateau at 0% (see Fig. S3 ). (C,D) Simulated curves (calculated for the three dilution factors measured) and diagrams of the two mechanisms tested in the kinetic analysis of the CD-followed unfolding of aSyn. Hp. A (C, inset) has the binding to lipid interfaces as a necessary and irreversible step in the coil-to-helix transition of the protein. Hp. B (D, inset), through the inclusion of a dynamic multimerization step, accounts for the shape of the measured curves and the changes observed in the serial dilutions of the sample. (E) Model of helical aSyn helical conformers as critical intermediates in physiology and pathology. Membrane-unbound aSyn can retain its helical fold and could thus undergo homo-oligomerization into helical multimers [6] (top). High-frequency synaptic activity, probably due to the constant membrane remodeling [18] , could shift this equilibrium toward the pool of aggregation-prone, unfolded, monomeric aSyn. [11, 21] . In accord with these apparently contrasting reports, fluorescence recovery after photobleaching (FRAP) experiments have measured aSyn's mobility, finding it to be lower than soluble but higher than membrane-associated proteins, and observing a constant exchange between membrane-bound and soluble aSyn, modulated by synaptic activity [18] . Our work shows how this physiological recycling mechanism could assist its refolding and generate a pool of soluble, aggregation-resistant helical multimers [6, 22] (Fig. 3E) . aSyn's homeostasis would then rest between two conformational pools: one of them aggregation-prone, soluble, and unfolded and the other a-helical and aggregation-resistant [6, 16, 23] . Imbalances in the relative amounts of protein in these two pools could favor nucleation events and subsequent aggregation [24] .
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